Search results
Showing 3286 to 3300 of 7691 results
Using our guidelines to help people make decisions about their care
Friday 22 July at 1:30pm via Zoom. Agenda Apologies for absence To receive any apologies for absence. Declarations of interest To declare
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS. Browse technology...
Kidney conditions: CKD urine albumin:creatinine ratio (IND144)
This indicator covers the percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM109
Information about transport layer security (TLS) 1.2 upgrade
NICE quality standards set out priority areas for quality improvement in health and social care.
Terms and conditions for the National Institute for Health and Care Excellence
CKS end user licence agreement
The National Institute for Health and Care Excellence's public task consists of the mandatory functions which it is under a legal duty to perform as...
Please complete all the required fields before submitting the form. RWE Navigator feedback form 1. Please tell us about yourself. Which
Healthcare professionals - shaping our work A wide range of healthcare professionals, including primary care colleagues, work with NICE to develop our
We work with an independent indicator advisory committee (IAC) to develop indicators suitable for inclusion in the Quality and Outcomes Framework...
Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
Artificial intelligence (AI) and digital regulations service
NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.
Support for industry to engage with NICE during all stages of health technology development